GlycoMimetics to Present Further Analysis of Data From Phase 1/2 AML Trial of Uproleselan at 61st ASH Meeting
Go back to GlycoMimetics to Present Further Analysis of Data From Phase 1/2 AML Trial of Uproleselan at 61st ASH Meeting| GLYCOMIMETICS (NASDAQ: GLYC) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $9.25 | |||
| Open | $0.16 | 52 Week Low | $3.70 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $0.00 | |||
| Volume | 2,330 | |||||
